BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6157855)

  • 1. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.
    Catalona WJ; Ratliff TL; McCool RE
    J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients.
    Catalona WJ; Ratliff TL; McCool RE
    Cancer Res; 1979 Nov; 39(11):4372-7. PubMed ID: 159124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E; Toge T; Tanada M; Hamamoto S; Seto Y; Kohno H; Hattori T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
    García MS; Barañao RI; Fernández O; Rumi LS
    Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Mar; 44(3):1275-80. PubMed ID: 6229330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased suppressor cell activity in disseminated granulomatous infections.
    Artz RP; Jacobson RR; Bullock WE
    Clin Exp Immunol; 1980 Aug; 41(2):343-52. PubMed ID: 6449336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental changes in humoral suppressor activity released from concanavalin A-stimulated human lymphocytes on B cell differentiation.
    Miyawaki T; Kubo M; Nagaoki T; Moriya N; Yokoi T; Mukai M; Taniguchi N
    J Immunol; 1981 May; 126(5):1720-3. PubMed ID: 6452476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor cell responses in patients with rheumatoid arthritis: the effect of thymosin.
    Zatz MM; Oliver J; Goldstein AL; Novak C; Jacobs RP
    Thymus; 1984; 6(4):205-18. PubMed ID: 6238454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of concanavalin A-activated suppressor cell activity by interferon.
    Moidel RA; Schwartz SA; Schnitzer TJ
    J Rheumatol; 1982; 9(5):665-70. PubMed ID: 6184473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Con A-induced suppressor cells in children with acute lymphoblastic leukaemia.
    Eibl M; Krepler P; Schmidmeier W; Zielinski C; Winterleitner H
    Clin Exp Immunol; 1980 Jun; 40(3):586-92. PubMed ID: 6448114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cell activity in peripheral blood in cancer patients after surgery.
    Grzelak I; Olszewski WL; Engeset A
    Clin Exp Immunol; 1983 Jan; 51(1):149-56. PubMed ID: 6219838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Con A suppressor cell assay: a further characterization.
    Meroni PL; Balestrieri G; Barcellini W; DeBartolo G; Fenini G; Tincani A; Zanussi C
    J Clin Lab Immunol; 1983 Mar; 10(3):159-63. PubMed ID: 6221109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective suppressor cell activity in essential mixed cryoglobulinemia.
    Meroni PL; Barcellini W; Messina C; De Bartolo G; Capsoni F; Invernizzi F
    J Clin Lab Immunol; 1982 Sep; 8(3):177-82. PubMed ID: 6215490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor cell activity of peripheral mononuclear cells from patients undergoing chronic haemodialysis.
    Guillou PJ; Woodhouse LF; Davison AM; Giles GR
    Biomedicine; 1980 Feb; 32(1):11-7. PubMed ID: 6445213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).
    Tomino S; Fujiwara H; Kagimoto T; Mitsuya H; Nishimura H; Kishimoto S
    Clin Exp Immunol; 1982 Jun; 48(3):625-32. PubMed ID: 6214341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset.
    Berd D; Mastrangelo MJ
    Cancer Res; 1987 Jun; 47(12):3317-21. PubMed ID: 2953413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of suppression of lymphocyte proliferation by Concanavalin A-activated mononuclear cells.
    Lomnitzer R; Rabson AR
    Immunology; 1981 Jul; 43(3):475-81. PubMed ID: 6454655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.